Drug Shortage Report for RENVELA

Last updated on 2019-01-10 History
Report ID 71284
Drug Identification Number 02354586
Brand name RENVELA
Common or Proper name Renvela
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) Sevelamer Carbonate
Strength(s) 800MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 180
ATC code V03AE
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-01-03
Estimated end date 2019-01-11
Actual end date 2019-01-09
Shortage status Resolved
Updated date 2019-01-10
Company comments
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-01-04 English Compare
v2 2019-01-04 French Compare
v3 2019-01-10 English Compare
v4 2019-01-10 French Compare